ADCYAP1 and Parkinson disease: This study shows that patients with PD have a significant negative correlation between PACAP levels and disease duration, suggesting that decreased serum PACAP levels may play an important role in the progression of this age-related disease, consistent with previous findings (Feher et al., 2018).